Matches in Wikidata for { <http://www.wikidata.org/entity/Q37639302> ?p ?o ?g. }
- Q37639302 description "article científic" @default.
- Q37639302 description "article scientifique" @default.
- Q37639302 description "articolo scientifico" @default.
- Q37639302 description "artigo científico" @default.
- Q37639302 description "artículu científicu espublizáu en 2017" @default.
- Q37639302 description "bilimsel makale" @default.
- Q37639302 description "bài báo khoa học" @default.
- Q37639302 description "scientific article published on 05 January 2017" @default.
- Q37639302 description "vedecký článok" @default.
- Q37639302 description "vetenskaplig artikel" @default.
- Q37639302 description "videnskabelig artikel" @default.
- Q37639302 description "vědecký článek" @default.
- Q37639302 description "wetenschappelijk artikel" @default.
- Q37639302 description "wissenschaftlicher Artikel" @default.
- Q37639302 description "наукова стаття, опублікована в січні 2017" @default.
- Q37639302 description "научни чланак" @default.
- Q37639302 description "مقالة علمية نشرت في 05 يناير 2017" @default.
- Q37639302 name "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 name "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 name "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 type Item @default.
- Q37639302 label "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 label "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 label "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 prefLabel "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 prefLabel "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 prefLabel "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 P1433 Q37639302-95A59271-EE5B-4D48-AE3F-794AD435C8D6 @default.
- Q37639302 P1476 Q37639302-85A427F0-053D-458C-89AB-2B1B1D8217EA @default.
- Q37639302 P2093 Q37639302-6905E3E1-5F68-47C5-9AB3-22EAB9E0E0AC @default.
- Q37639302 P2093 Q37639302-69563488-B7A2-40FE-BC39-23451681CFC7 @default.
- Q37639302 P2093 Q37639302-C0F29DB4-D1D2-4C8B-A07E-E0AC3E0EA65F @default.
- Q37639302 P2093 Q37639302-D15289EC-F799-4113-A33E-B932403CAD0E @default.
- Q37639302 P275 Q37639302-8d63cd02-cc70-4d94-bd7d-9671875a8c9f @default.
- Q37639302 P2860 Q37639302-0A2A6053-E746-4568-A215-4D8B74E9740E @default.
- Q37639302 P2860 Q37639302-1128ADAA-4342-4215-A834-CC8E47C1C678 @default.
- Q37639302 P2860 Q37639302-16BA96BD-58E9-44DB-AFA0-8E574DCC6CDD @default.
- Q37639302 P2860 Q37639302-25F68813-8DCB-45B4-9551-19356F652E48 @default.
- Q37639302 P2860 Q37639302-2739E2F1-322D-46AC-B20E-EE7C33A56560 @default.
- Q37639302 P2860 Q37639302-2A8AD3CE-B1C8-4A6D-ACAA-C763BD0BB930 @default.
- Q37639302 P2860 Q37639302-2BF8EECD-649A-4B71-AEA3-A3E5DB3401D8 @default.
- Q37639302 P2860 Q37639302-2D0D3925-0D30-4A36-9C6F-C53605F1D775 @default.
- Q37639302 P2860 Q37639302-361ADF33-BF4D-4448-964F-F37EF1B14956 @default.
- Q37639302 P2860 Q37639302-45CEE628-F59D-454F-96E5-87B45688F7CF @default.
- Q37639302 P2860 Q37639302-48521DAD-BB53-4A69-8288-6F82DCEAEDF2 @default.
- Q37639302 P2860 Q37639302-49E29444-51A6-4307-B320-4500B004A4F3 @default.
- Q37639302 P2860 Q37639302-4AA5D553-65D1-4FFE-A867-C953A5FCC611 @default.
- Q37639302 P2860 Q37639302-4B985BC4-CC38-4BE7-9F12-40FA165E0F36 @default.
- Q37639302 P2860 Q37639302-5DDFEC07-F1A6-4A93-9B32-DA3F681DBEB6 @default.
- Q37639302 P2860 Q37639302-667352E9-BB47-42A1-AD2C-41F74CC5FD19 @default.
- Q37639302 P2860 Q37639302-68B39D39-B655-427E-993B-30B96C9169B3 @default.
- Q37639302 P2860 Q37639302-68D70743-7D69-46F9-8A20-A842B8DF40F1 @default.
- Q37639302 P2860 Q37639302-6C7511A8-EB63-4B81-ACB4-F8FBBB67EB41 @default.
- Q37639302 P2860 Q37639302-6F5BF615-A7E7-427B-B7D8-2659C4FC5B9E @default.
- Q37639302 P2860 Q37639302-7601F7CA-8D0D-4A17-9A2B-B044490EC110 @default.
- Q37639302 P2860 Q37639302-7F601E70-5AF0-4971-92B4-BE8597824FD2 @default.
- Q37639302 P2860 Q37639302-8CD39B5C-3E3B-4E3E-80E7-E5C8FC3F6FC0 @default.
- Q37639302 P2860 Q37639302-8D7121A9-31D8-4187-9DDE-C98D735A9FB1 @default.
- Q37639302 P2860 Q37639302-96254284-7FD1-4C16-8FB3-F7B5DBCED841 @default.
- Q37639302 P2860 Q37639302-9DCEFA0D-6A48-40D7-8CF4-3C486775419D @default.
- Q37639302 P2860 Q37639302-9EAC3C31-391A-4E7A-A10F-81E8CF171241 @default.
- Q37639302 P2860 Q37639302-C2C88FFA-96D6-4F57-B527-6B192B1E12DA @default.
- Q37639302 P2860 Q37639302-CC48D71B-8718-4569-B0F0-66B7BFA6AAE3 @default.
- Q37639302 P2860 Q37639302-CC9B40E8-5D5B-4F67-9077-AEA272499723 @default.
- Q37639302 P2860 Q37639302-CE7A032E-FFE5-46C6-AB2F-1DDC2DEED0A8 @default.
- Q37639302 P2860 Q37639302-CF1CC27F-0684-4310-A4FE-E89762E5480E @default.
- Q37639302 P2860 Q37639302-D76FAF23-A688-4F47-8062-B5A8E85FCE07 @default.
- Q37639302 P2860 Q37639302-D90E8638-D90E-4D6A-BBA2-19588D2997A1 @default.
- Q37639302 P2860 Q37639302-DFC0E375-118C-41AA-8F66-789205C6850C @default.
- Q37639302 P2860 Q37639302-E5CC5F51-41AC-4263-A1A9-A9B41028D47F @default.
- Q37639302 P2860 Q37639302-E609A828-D2D7-4817-A64F-6E7E8D6D4142 @default.
- Q37639302 P2860 Q37639302-EFCD7AEE-F797-4A89-AB74-117F60378C16 @default.
- Q37639302 P2860 Q37639302-F49E47B5-E097-4F75-8F73-BB6528A48CB6 @default.
- Q37639302 P2860 Q37639302-FC915741-66FE-417A-8DEE-16B889374AA0 @default.
- Q37639302 P2888 Q37639302-321CA4C0-235F-4E3D-BBE7-65F7E5220C94 @default.
- Q37639302 P304 Q37639302-15602602-3E9A-42B8-ABE1-B6D907DD488D @default.
- Q37639302 P31 Q37639302-2F72A14E-48CC-41B2-A712-01B76DFB6053 @default.
- Q37639302 P356 Q37639302-630F421B-8291-4EED-BA48-EEB220F53149 @default.
- Q37639302 P407 Q37639302-74E66AA4-88E9-4778-95D7-5A4B90755370 @default.
- Q37639302 P433 Q37639302-F683EB3B-5CFD-4B51-9FA9-CA190AF3FEF2 @default.
- Q37639302 P478 Q37639302-8D063B0D-B167-4112-88E5-BE98A242D22D @default.
- Q37639302 P577 Q37639302-93E5FEBD-85D8-4682-AC38-96D74AE74DAB @default.
- Q37639302 P6216 Q37639302-3ad5d559-cb93-4c2e-8fb4-d4cc5779f409 @default.
- Q37639302 P698 Q37639302-D7FAF0EB-4E58-4049-96CD-288EC940243E @default.
- Q37639302 P921 Q37639302-24998A24-02F4-4D19-A9F3-9B404243E9C8 @default.
- Q37639302 P921 Q37639302-2F623634-5B59-462A-8BE8-2224B14927B1 @default.
- Q37639302 P932 Q37639302-9741F540-22F2-4077-8256-56886ED28F16 @default.
- Q37639302 P356 S13300-016-0219-2 @default.
- Q37639302 P698 28058656 @default.
- Q37639302 P1433 Q26853803 @default.
- Q37639302 P1476 "Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom" @default.
- Q37639302 P2093 "Barnaby Hunt" @default.
- Q37639302 P2093 "Donna Ashley" @default.
- Q37639302 P2093 "Qing Ye" @default.
- Q37639302 P2093 "William J Valentine" @default.
- Q37639302 P275 Q20007257 @default.
- Q37639302 P2860 Q24608301 @default.
- Q37639302 P2860 Q24652963 @default.
- Q37639302 P2860 Q24656644 @default.
- Q37639302 P2860 Q26799389 @default.